Cited by 712Venous Thromboembolism Diagnosis and ManagementReproductive Health and ContraceptionBlood Coagulation and Thrombosis Mechanisms

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Hormonal contraception and risk of venous thromboembolism: national follow-up study

Open access

Lidegaard, O., Lokkegaard, E., Svendsen, A. L., Agger, C.·2009·BMJ

DOI 10.1136/bmj.b2890PMC PMC2726928

Open this paper in CoChat — free account Open PDF

Abstract

OBJECTIVE: To assess the risk of venous thrombosis in current users of different types of hormonal contraception, focusing on regimen, oestrogen dose, type of progestogen, and route of administration. DESIGN: National cohort study. SETTING: Denmark, 1995-2005. PARTICIPANTS: Danish women aged 15-49 with no history of cardiovascular or malignant disease. MAIN OUTCOME MEASURES: Adjusted rate ratios for all first time deep venous thrombosis, portal thrombosis, thrombosis of caval vein, thrombosis of renal vein, unspecified deep vein thrombosis, and pulmonary embolism during the study period. RESULTS: 10.4 million woman years were recorded, 3.3 million woman years in receipt of oral contraceptives. In total, 4213 venous thrombotic events were observed, 2045 in current users of oral contraceptives. The overall absolute risk of venous thrombosis per 10 000 woman years in non-users of oral contraceptives was 3.01 and in current users was 6.29. Compared with non-users of combined oral contraceptives the rate ratio of venous thrombembolism in current users decreased with duration of use (<1 year 4.17, 95% confidence interval 3.73 to 4.66, 1-4 years 2.98, 2.73 to 3.26, and >4 years 2.76, 2.53 to 3.02; P<0.001) and with decreasing dose of oestrogen. Compared with oral contraceptives containing levonorgestrel and with the same dose of oestrogen and length of use, the rate ratio for oral contraceptives with norethisterone was 0.98 (0.71 to 1.37), with norgestimate 1.19 (0.96 to 1.47), with desogestrel 1.82 (1.49 to 2.22), with gestodene 1.86 (1.59 to 2.18), with drospirenone 1.64 (1.27 to 2.10), and with cyproterone 1.88 (1.47 to 2.42). Compared with non-users of oral contraceptives, the rate ratio for venous thromboembolism in users of progestogen only oral contraceptives with levonorgestrel or norethisterone was 0.59 (0.33 to 1.03) or with 75 mug desogestrel was 1.12 (0.36 to 3.49), and for hormone releasing intrauterine devices was 0.90 (0.64 to 1.26). CONCLUSION: The risk of venous thrombosis in current users of combined oral contraceptives decreases with duration of use and decreasing oestrogen dose. For the same dose of oestrogen and the same length of use, oral contraceptives with desogestrel, gestodene, or drospirenone were associated with a significantly higher risk of venous thrombosis than oral contraceptives with levonorgestrel. Progestogen only pills and hormone releasing intrauterine devices were not associated with any increased risk of venous thrombosis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1136/bmj.b2890

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Risk of idiopathic cardiovascular death and rionfatal venous thromboembolism in women using oral contraceptives with differing progestagen components
Jick, H., Jick, S. S., Myers, M. W., Vasilakis‐Scaramozza, C., & Gurewich, V. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91928-7 · Cited by 721
Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study
Spitzer, W. O., Lewis, M. A., Heinemann, L. A. J., Thorogood, M., & MacRae, K. D. (1996) · BMJ · doi:10.1136/bmj.312.7023.83 · Cited by 590
Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen
Bloemenkamp, K. W. M., Helmerhorst, F. M., Rosendaal, F. R., Vandenbroucke, J. P., & Buller, H. R. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91929-5 · Cited by 576
The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance study on Oral Contraceptives based on 142,475 women-years of observation
Dinger, J. C., Heinemann, L. A. J., & Kühl-Habich, D. (2007) · Contraception · doi:10.1016/j.contraception.2006.12.019 · Cited by 472
Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
Poulter, N. R., Cl, C., Farley, T., Meirik, O., & Marmot, M. G. (1995) · PubMed · Cited by 404
Oral contraceptives and venous thromboembolism: a five-year national case-control study☆
Lidegaard, Ø., Edström, B., & Kreiner, S. (2002) · Contraception · doi:10.1016/s0010-7824(01)00307-9 · Cited by 332
Population-based study of risk of venous thromboembolism associated with various oral contraceptives
Farmer, R., Lawrenson, R., Thompson, C., Kennedy, J., & Hambleton, I. R. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07496-x · Cited by 329
Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
Farley, T., Meirik, O., Cl, C., Marmot, M. G., & Poulter, N. R. (1995) · PubMed · Cited by 319
Venous thromboembolic disease and combined oral contraceptives: Results of international multicentre case‐control study
(1996) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(96)89711-6 · Cited by 259
Risk of venous thromboembolism among users of third generation oral contraceptives compared with users of oral contraceptives with levonorgestrel before and after 1995: cohort and case-control analysis
Jick, H. (2000) · BMJ · doi:10.1136/bmj.321.7270.1190 · Cited by 193

Flagged first, then by citations

Show all 29 references

Sorted by citations

Items 101–200 of 712

Toward a Lowest Effective Dose of Cyproterone Acetate in Trans Women: Results From the ENIGI Study
Kuijpers, S. M. E., Wiepjes, C. M., Conemans, E. B., Fisher, A. D., T’Sjoen, G., & den Heijer, M. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab427 · Cited by 61
Paediatric arterial ischaemic stroke and cerebral sinovenous thrombosis in Denmark 1994–2006: A nationwide population‐based study
Tuckuviene, R., Christensen, A.-E., Helgestad, J., Johnsen, S. P., & Kristensen, S. R. (2010) · Acta Paediatrica · doi:10.1111/j.1651-2227.2010.02100.x · Cited by 60
Hormonal contraception in women with migraine: is progestogen-only contraception a better choice?
Nappi, R. E., Merki‐Feld, G. S., Terreno, E., Pellegrinelli, A., & Viana, M. (2013) · The Journal of Headache and Pain · doi:10.1186/1129-2377-14-66 · Cited by 59
Systemic hormonal contraception and risk of venous thromboembolism
Heikinheimo, O., Toffol, E., Partonen, T., But, A., Latvala, A., & Haukka, J. (2022) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.14384 · Cited by 58
Vaginal ring contraception
Kerns, J., & Darney, P. D. (2010) · Contraception · doi:10.1016/j.contraception.2010.07.008 · Cited by 58
2020 Clinical practice guidelines for Pulmonary hypertension, including chronic thromboembolic pulmonary hypertension
Avdeev, S. N., Барбараш, О. Л., Баутин, А. Е., Volkov, A. V., Veselova, T. N., Galyavich, A. S., Goncharova, N. S., Gorbachevsky, S. V., Danilov, N. M., Еременко, А. А., et al. (2021) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2021-4683 · Cited by 57
Hormonal contraception, thrombosis and age
Lidegaard, Ø. (2014) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2014.950654 · Cited by 57
Oral Contraceptives and Venous Thromboembolism
Reid, R. L., Westhoff, C. L., Mansour, D., de Vries, C., Verhaeghe, J., Boschitsch, E., Gompel, A., Birkhäuser, M., Křepelka, P., Ďulíček, P., et al. (2010) · Journal of Family Planning and Reproductive Health Care · doi:10.1783/147118910791749425 · Cited by 56
The state of hormonal contraception today: benefits and risks of hormonal contraceptives: combined estrogen and progestin contraceptives
SHULMAN, L. P. (2011) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2011.06.057 · Cited by 56
Progestin-only contraception compared with extended combined oral contraceptive in women with migraine without aura: a retrospective pilot study
Morotti, M., Remorgida, V., Venturini, P. L., & Ferrero, S. (2014) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2014.10.029 · Cited by 55
Risk of venous thromboembolism among users of oral contraceptives: a review of two recently published studies
Shapiro, S., & Dinger, J. (2010) · Journal of Family Planning and Reproductive Health Care · doi:10.1783/147118910790291037 · Cited by 55
The Role of Estrogen in the Treatment of Men with Schizophrenia
Kulkarni, J., Gavrilidis, E., Worsley, R., Rheenen, T. E. V., & Hayes, E. (2013) · Intern J Endocrinol Metab · doi:10.5812/ijem.6615 · Cited by 55
Cardiovascular risks associated with the use of drospirenone-containing combined oral contraceptives
Dinger, J., Möhner, S., & Heinemann, K. (2016) · Contraception · doi:10.1016/j.contraception.2016.01.012 · Cited by 55
Progesterone in Addition to Standard of Care vs Standard of Care Alone in the Treatment of Men Hospitalized With Moderate to Severe COVID-19
Ghandehari, S., Matusov, Y. P., Pepkowitz, S. H., Stein, D. G., Kaderi, T., Narayanan, D., Hwang, J. Y. T., Chang, S. H., Goodman, R., Ghandehari, H., et al. (2021) · CHEST Journal · doi:10.1016/j.chest.2021.02.024 · Cited by 54
Ovarian reserve markers after discontinuing long-term use of combined oral contraceptives
Landersoe, S. K., Petersen, K. B., Sørensen, A. L., Larsen, E. C., Martinussen, T., Lunding, S. A., Kroman, M. S., Nielsen, H. S., & Andersen, A. N. (2019) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2019.10.004 · Cited by 54
Venous thromboembolism associated with pregnancy and hormonal therapy
Jacobsen, A. F., & Sandset, P. M. (2012) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2012.07.006 · Cited by 53
Progestin-only contraception and venous thromboembolism
Blanco-Molina, M. Á., Lozano, M., Cano, A., García, I. C., Pallardó, L., & Lete, I. (2012) · Thrombosis Research · doi:10.1016/j.thromres.2012.02.042 · Cited by 52
Long‐term use of dienogest for the treatment of primary and secondary dysmenorrhea
Osuga, Y., Hayashi, K., & Kanda, S. (2020) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.14209 · Cited by 51
Thrombosis in women: what are the knowledge gaps in 2013?
Middeldorp, S. (2013) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12266 · Cited by 50
Provision of Contraceptive Services to Women with Diabetes Mellitus
Schwarz, E. B., Postlethwaite, D., Hung, Y., Lantzman, E., Armstrong, M. A., & Horberg, M. A. (2011) · Journal of General Internal Medicine · doi:10.1007/s11606-011-1875-6 · Cited by 50
Mechanisms of hormonal therapy related thrombosis
Sandset, P. M. (2013) · Thrombosis Research · doi:10.1016/s0049-3848(13)70009-4 · Cited by 49
Bleeding profile of a flexible extended regimen of ethinylestradiol/drospirenone in US women: an open-label, three-arm, active-controlled, multicenter study
Jensen, J. T., Garie, S. G., Trummer, D., & Elliesen, J. (2012) · Contraception · doi:10.1016/j.contraception.2011.12.009 · Cited by 48
Menstrual Disorders in Adolescents: Review of Current Practice
Williams, C. E., & Creighton, S. M. (2012) · Hormone Research in Paediatrics · doi:10.1159/000342822 · Cited by 48
Haemostatic and metabolic impact of estradiol pills and drospirenone-containing ethinylestradiol pills vs. levonorgestrel-containing ethinylestradiol pills: A literature review
Lete, I., Chabbert‐Buffet, N., Jamin, C., Lello, S., Lobo, P., Nappi, R. E., & Pintiaux, A. (2015) · The European Journal of Contraception & Reproductive Health Care · doi:10.3109/13625187.2015.1050091 · Cited by 47
Analysis of Risk Factors of Stroke and Venous Thromboembolism in Females With Oral Contraceptives Use
Ďulíček, P., Ivanova, E. Y., Košťál, M., Sadílek, P., Beránek, M., Зак, П., & Hirmerová, J. (2017) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029617727857 · Cited by 47
Polycystic ovary syndrome: A review for dermatologists
Buzney, E. A., Sheu, J., Buzney, C. D., & Reynolds, R. V. (2014) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2014.05.009 · Cited by 47
Low Thrombin Generation in Users of a Contraceptive Containing Estetrol and Drospirenone
Morimont, L., Jost, M., GASPARD, U. J., Foidart, J., Dogné, J.-M., & Douxfils, J. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac511 · Cited by 46
Effects of the menstrual and oral contraceptive cycle phases on microvascular reperfusion
Mattu, A. T., MacInnis, M. J., Doyle–Baker, P. K., & Murias, J. M. (2019) · Experimental Physiology · doi:10.1113/ep088135 · Cited by 46
Hormone replacement therapy and venous thromboembolism
Eisenberger, A. B., & Westhoff, C. L. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.08.016 · Cited by 45
Epidemiology of the contraceptive pill and venous thromboembolism
Hannaford, P. C. (2011) · Thrombosis Research · doi:10.1016/s0049-3848(11)70009-3 · Cited by 45
Emergency Evaluation for Pulmonary Embolism, Part 1: Clinical Factors that Increase Risk
Kline, J. A., & Kabrhel, C. (2015) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2014.12.040 · Cited by 46
Association between polycystic ovary syndrome and venous thromboembolism: A systematic review and meta-analysis
Gariani, K., Hugon‐Rodin, J., Philippé, J., Righini, M., & Blondon, M. (2019) · Thrombosis Research · doi:10.1016/j.thromres.2019.11.019 · Cited by 45
Hormonal Contraception
Wiegratz, I., & Thaler, C. (2011) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2011.0495 · Cited by 45
Evaluation of a new estradiol oral contraceptive: estradiol valerate and dienogest
Jensen, J. T. (2010) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656561003724713 · Cited by 45
Risk factors for venous thromboembolism in pre-and postmenopausal women
Bergendal, A., Bremme, K. A., Hedenmalm, K., Lärfars, G., Odeberg, J., Persson, I. R., Sundström, A., & Kieler, H. (2012) · Thrombosis Research · doi:10.1016/j.thromres.2012.05.024 · Cited by 43
Risk factors for recurrence of venous thromboembolism associated with the use of oral contraceptives
Vaillant-Roussel, H., Ouchchane, L., Dauphin, C., Philippe, P., & Ruivard, M. (2011) · Contraception · doi:10.1016/j.contraception.2011.06.008 · Cited by 43
Duration of oral contraceptive use and the risk of venous thromboembolism. A case-control study
Martinelli, I., Maino, A., Abbattista, M., Bucciarelli, P., Passamonti, S. M., Artoni, A., Gianniello, F., & Peyvandi, F. (2016) · Thrombosis Research · doi:10.1016/j.thromres.2016.03.025 · Cited by 42
Gestodene: A review of its pharmacology, potency and tolerability in combined contraceptive preparations
Stanczyk, F. Z., & Archer, D. F. (2013) · Contraception · doi:10.1016/j.contraception.2013.12.003 · Cited by 42
Contraception and the media: lessons past, present and future
Foran, T. (2019) · The European Journal of Contraception & Reproductive Health Care · doi:10.1080/13625187.2018.1563067 · Cited by 42
Oral contraceptives and the serotonin 4 receptor: a molecular brain imaging study in healthy women
Larsen, S. V., Köhler‐Forsberg, K., Dam, V. H., Poulsen, A. S., Svarer, C., Jensen, P. S., Knudsen, G. M., Fisher, P. M., Ozenne, B., & Frøkjær, V. G. (2020) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13211 · Cited by 42
A case of thrombocytopenia and multiple thromboses after vaccination with ChAdOx1 nCoV-19 against SARS-CoV-2
Sørensen, A. L. T., Rolland, M., Hartmann, J. P., Harboe, Z. B., Roed, C., Jensen, T. Ø., Kolte, L., Fassi, D. E., Hillingsø, J., Radziwon‐Balicka, A., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2021004904 · Cited by 41
Hormonal contraception in women at risk of vascular and metabolic disorders: Guidelines of the French Society of Endocrinology
Gourdy, P., Bachelot, A., Catteau-Jonard, S., Chabbert‐Buffet, N., Christin‐Maître, S., Conard, J., Fredenrich, A., Gompel, A., Lamiche-Lorenzini, F., Moreau, C., et al. (2012) · Annales d Endocrinologie · doi:10.1016/j.ando.2012.09.001 · Cited by 40
Combined oral contraceptives, venous thromboembolism, and the problem of interpreting large but incomplete datasets
Dinger, J., & Shapiro, S. (2011) · Journal of Family Planning and Reproductive Health Care · doi:10.1136/jfprhc-2011-100260 · Cited by 39
Headache frequency and intensity in female migraineurs using desogestrel-only contraception: A retrospective pilot diary study
Merki‐Feld, G. S., Imthurn, B., Langner, R., Sándor, P. S., & Gantenbein, A. R. (2013) · Cephalalgia · doi:10.1177/0333102412473373 · Cited by 39
Position of the Spanish Menopause Society regarding the management of perimenopause
Mendoza, N., Sánchez‐Borrego, R., Hidalgo, M. J. C., Calvo, A., Checa, M. Á., Cortés, J., Elorriaga, M. Á., Díaz, T., González, J. V., Lete, I., et al. (2013) · Maturitas · doi:10.1016/j.maturitas.2012.12.010 · Cited by 39
2025 ACC/AHA/HRS/ISACHD/SCAI Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Gurvitz, M. Z., Krieger, E. V., Fuller, S., Davis, L. L., Kittleson, M. M., Aboulhosn, J., Bradley, E. A., Buber, J., Daniels, C. J., Dimopoulos, K., et al. (2025) · Circulation · doi:10.1161/cir.0000000000001402 · Cited by 38
Contraception and Hormonal Management in the Perimenopause
Long, M. E., Faubion, S. S., MacLaughlin, K. L., Pruthi, S., & Casey, P. M. (2014) · Journal of Women s Health · doi:10.1089/jwh.2013.4544 · Cited by 37
Acquired thrombotic risk factors in the critical care setting
Ortel, T. L. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181c9ccc8 · Cited by 35
Hormonal contraceptive use in Norway, 2006-2020, by contraceptive type, age and county: A nationwide register-based study
Furu, K., Aares, E. B., Hjellvik, V., & Karlstad, Ø. (2021) · Norsk Epidemiologi · doi:10.5324/nje.v29i1-2.4046 · Cited by 34
Hypercoagulability in adolescent girls on oral contraceptives‐global coagulation profile and estrogen receptor polymorphisms
Zia, A. N., Callaghan, M. U., Callaghan, J. H., Sawni, A., Bartlett, H., Backos, A., Marshall, S. P., Chitlur, M., & Rajpurkar, M. (2015) · American Journal of Hematology · doi:10.1002/ajh.24064 · Cited by 34
Comparative Study of the Effects of Combined Oral Contraceptives in Hemostatic Variables
Stocco, B., Fumagalli, H. F., Franceschini, S. A., Martínez, E. Z., Marzocchi-Machado, C. M., de Sá, M. F. S., & Tolói, M. R. T. (2015) · Medicine · doi:10.1097/md.0000000000000385 · Cited by 34
Proteomics in cardiovascular diseases: Unveiling sex and gender differences in the era of precision medicine
Baetta, R., Pontremoli, M., Martínez, A. E., Spickett, C. M., & Banfi, C. (2017) · Journal of Proteomics · doi:10.1016/j.jprot.2017.11.012 · Cited by 33
The role of traditional contraceptive methods in family planning among women attending primary health care centers in Kano
Rabiu, A., & Rufa'i, A. (2018) · Annals of African Medicine · doi:10.4103/aam.aam_60_17 · Cited by 33
50 years of “The Pill”: celebrating a golden anniversary
Szarewski, A., Mansour, D., & SHULMAN, L. P. (2010) · Journal of Family Planning and Reproductive Health Care · doi:10.1783/147118910793048665 · Cited by 34
No evidence that assisted reproduction increases the risk of thrombosis: a Danish National cohort study
Hansen, A. T., Kesmodel, U. S., Juul, S., & Hvas, A. (2012) · Human Reproduction · doi:10.1093/humrep/des041 · Cited by 33
Postpartum Contraception
Sober, S., & Schreiber, C. A. (2014) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000055 · Cited by 33
Risk of recurrent venous thromboembolism among young women after a first event while exposed to combined oral contraception versus not exposed to: A cohort study
Moigne, E. L., Delluc, A., Tromeur, C., Nowak, E., Mottier, D., Lacut, K., & Gal, G. L. (2013) · Thrombosis Research · doi:10.1016/j.thromres.2013.05.028 · Cited by 33
Venous thromboembolism in women taking hormonal contraceptives
Blanco-Molina, Á., & Monréal, M. (2010) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.09.175 · Cited by 32
Cardiovascular risk and the use of oral contraceptives.
Kamiński, P., Szpotanska‐Sikorska, M., & Wielgoś, M. (2013) · PubMed · Cited by 31
Investigating the anti-mineralocorticoid properties of synthetic progestins used in hormone therapy
Africander, D., Toit, R. L.-D., & Hapgood, J. P. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.02.086 · Cited by 31
RETIRED: Oral Contraceptives and the Risk of Venous Thromboembolism: An Update
Reid, R. L., Leyland, N. A., Wolfman, W., Allaire, C., Awadalla, A., Best, C., Dunn, S., Lemyre, M., Marcoux, V., Ménard, C., et al. (2010) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)34746-6 · Cited by 31
The Risk of Venous Thromboembolism with Different Generation of Oral Contraceptives; a Systematic Review and Meta-Analysis.
Baratloo, A., Safari, S., Rouhipour, A., Hashemi, B., Rahmati, F., Motamedi, M., Forouzanfar, M., & Haroutunian, P. (2014) · Archives of Academic Emergency Medicine · doi:10.22037/aaem.v2i1.14 · Cited by 30
Long-term tolerability of ethinylestradiol 20 µg/drospirenone 3 mg in a flexible extended regimen: results from a randomised, controlled, multicentre study
Klipping, C., Duijkers, I. J. M., Fortier, M. P., Marr, J., Trummer, D., & Elliesen, J. (2012) · Journal of Family Planning and Reproductive Health Care · doi:10.1136/jfprhc-2011-100214 · Cited by 30
Pregnancy in women with congenital heart disease: a focus on management and preventing the risk of complications
Wander, G., van der Zande, J. A., Patel, R., Johnson, M. R., & Roos‐Hesselink, J. W. (2023) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2023.2237886 · Cited by 31
Minimizing Venous Thromboembolism in Feminizing Hormone Therapy: Applying Lessons From Cisgender Women and Previous Data
Zucker, R., Reisman, T., & Safer, J. D. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2021.03.010 · Cited by 29
Venous Thromboembolism in Oral and Maxillofacial Surgery: A Review of the Literature
Williams, B., Indresano, A. T., & O’Ryan, F. (2011) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2010.11.025 · Cited by 29
Oral contraceptives and venous thromboembolism: old questions revisited
Dinger, J. (2009) · Journal of Family Planning and Reproductive Health Care · doi:10.1783/147118909789587385 · Cited by 29
Development of controlled release systems over the past 50 years in the area of contraception
Friend, D. R. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.12.043 · Cited by 29
International Active Surveillance Study of Women Taking Oral Contraceptives (INAS-OC Study)
Dinger, J. C., Bardenheuer, K., & Assmann, A. (2009) · BMC Medical Research Methodology · doi:10.1186/1471-2288-9-77 · Cited by 29
Progestin-only pills for contraception
Grimes, D. A., Lopez, L. M., O'Brien, P. A., & Raymond, E. G. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007541.pub2 · Cited by 29
Impact of the sharp changes in the use of contraception in 2013 on the risk of pulmonary embolism in France
Tricotel, A., Collin, C., & Zureik, M. (2015) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13053 · Cited by 28
Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism
Bitzer, J., Amy, J., Beerthuizen, R. J. C. M., Birkhäuser, M., Bombas, T., Creinin, M. D., Darney, P. D., Vicente, L. F., Gemzell‐Danielsson, K., Imthurn, B., et al. (2013) · The European Journal of Contraception & Reproductive Health Care · doi:10.3109/13625187.2013.792637 · Cited by 28
Desogestrel-only contraception may reduce headache frequency and improve quality of life in women suffering from migraine
Merki‐Feld, G. S., Imthurn, B., Seifert, B., Merki, L. L., Agosti, R. M., & Gantenbein, A. R. (2013) · The European Journal of Contraception & Reproductive Health Care · doi:10.3109/13625187.2013.814769 · Cited by 28
Acquired Thrombophilia
Armstrong, E. M., Bellone, J. M., Hornsby, L. B., Eudaley, S. T., & Phillippe, H. M. (2014) · Journal of Pharmacy Practice · doi:10.1177/0897190014530424 · Cited by 31
Current Issues in Contraception
Marnach, M. L., Long, M. E., & Casey, P. M. (2013) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2013.01.007 · Cited by 28
Duration of anticoagulant therapy for venous thromboembolism: balancing benefits and harms on the long term
de Jong, P. G., Coppens, M., & Middeldorp, S. (2012) · British Journal of Haematology · doi:10.1111/j.1365-2141.2012.09196.x · Cited by 27
An unusual presentation of acute deep vein thrombosis after the Moderna COVID-19 vaccine—a case report
Bhan, C., Bheesham, N., Shakuntulla, F., Sharma, M., Sun, C., & Weinstein, M. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-2772 · Cited by 27
FSRH Guideline (January 2019, amended October 2023) Combined Hormonal Contraception
(2019) · BMJ Sexual & Reproductive Health · doi:10.1136/bmjsrh-2018-chc · Cited by 27
Does the Progestogen Used in Combined Hormonal Contraception Affect Venous Thrombosis Risk?
Han, L. L., & Jensen, J. T. (2015) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2015.07.007 · Cited by 27
Effect of extended-cycle regimen with an oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest on bleeding patterns, safety, acceptance and contraceptive efficacy
Wiegratz, I., Stahlberg, S., Manthey, T., Sänger, N., Mittmann, K., Lange, E., Mellinger, U., Palombo‐Kinne, E., & Kühl, H. (2011) · Contraception · doi:10.1016/j.contraception.2011.01.002 · Cited by 27
The effect of different hormonal contraceptives on plasma levels of free protein S and free TFPI
Helmerhorst, F. M., Fleischer, K., Dahm, A. E. A., Rosendaal, F. R., Rosing, J., Reitsma, P. H., Sandset, P. M., van Vliet, H. A. A. M., & Raps, M. (2013) · Thrombosis and Haemostasis · doi:10.1160/th12-10-0771 · Cited by 27
Positive effects of the progestin desogestrel 75 μg on migraine frequency and use of acute medication are sustained over a treatment period of 180 days
Merki‐Feld, G. S., Imthurn, B., Langner, R., Seifert, B., & Gantenbein, A. R. (2015) · The Journal of Headache and Pain · doi:10.1186/s10194-015-0522-8 · Cited by 26
Sex hormone‐binding globulin levels are not causally related to venous thrombosis risk in women not using hormonal contraceptives
Stegeman, B. H., Helmerhorst, F. M., Vos, H. L., Rosendaal, F. R., & Vlieg, A. V. H. (2012) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2012.04878.x · Cited by 25
Hormonal Contraceptive Use Among Adolescent Girls in Germany in Relation to Health Behavior and Biological Cardiovascular Risk Factors
Du, Y., Rosner, B. M., Knopf, H. C., Schwarz, S., Dören, M., & Scheidt‐Nave, C. (2011) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2011.01.004 · Cited by 25
Drug safety evaluation of desogestrel
Scala, C., Maggiore, U. L. R., Remorgida, V., Venturini, P. L., & Ferrero, S. (2013) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2013.788147 · Cited by 25
Risk of Venous Thromboembolism with Drospirenone in Combined Oral Contraceptive Products
Sehovic, N., & Smith, K. P. (2010) · Annals of Pharmacotherapy · doi:10.1345/aph.1m649 · Cited by 25
Thromboembolic Events in Women Exposed to Hormonal Contraception or Cyproterone Acetate in 2012: A Cross-Sectional Observational Study in 30 French Public Hospitals
Gourbil, M., Grandvuillemin, A., Beyens, M., Massy, N., Gras, V., Damico, A. B., Miremont‐Salamé, G., & Petitpain, N. (2014) · Drug Safety · doi:10.1007/s40264-014-0149-8 · Cited by 24
Resistance to APC and SHBG levels during use of a four-phasic oral contraceptive containing dienogest and estradiol valerate: a randomized controlled trial
Raps, M., Rosendaal, F. R., Ballieux, B. E. P. B., Rosing, J., Thomassen, S., Helmerhorst, F. M., & van Vliet, H. A. A. M. (2013) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12172 · Cited by 24
Progestin-only contraception and thrombosis: An updated systematic review
Tepper, N. K., Nguyen, A. T., Whiteman, M. K., & Curtis, K. M. (2025) · Contraception · doi:10.1016/j.contraception.2025.110978 · Cited by 23
Symptomatic Venous Thromboembolism Following Fractures Distal to the Knee
Wahlsten, L. R., Eckardt, H., Lyngbæk, S., Jensen, P. F., Fosbøl, E. L., Torp-Pedersen, C. T., Gislason, G., & Olesen, J. B. (2015) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.n.00307 · Cited by 23
Risk factors for venous thromboembolism during pregnancy
Jensen, T. B., Gerds, T. A., Grøn, R., Bretler, D., Schmiegelow, M., Andersson, C., Azimi, A., Gislason, G., Torp-Pedersen, C. T., & Olesen, J. B. (2013) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3536 · Cited by 23
The relationship between unplanned pregnancy and maternal body mass index 2009–2012
McKeating, A., O'Higgins, A. C., Turner, C., McMahon, L. E., Sheehan, S. R., & Turner, M. J. (2015) · The European Journal of Contraception & Reproductive Health Care · doi:10.3109/13625187.2015.1023893 · Cited by 23
Drospirenone and non-fatal venous thromboembolism: Is there a risk difference by dosage of ethinyl-estradiol?
Bird, S. T., Delaney, J. A. C., Etminan, M., Brophy, J. M., & Hartzema, A. G. (2013) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12224 · Cited by 22
Combined oral contraceptives may activate the contact system in healthy women
Strandberg, J., Gade, I. L., Palarasah, Y., Gram, J., Kristensen, S. R., & Sidelmann, J. J. (2023) · Research and Practice in Thrombosis and Haemostasis · doi:10.1016/j.rpth.2023.100118 · Cited by 22
The changing face of cerebral venous sinus thrombosis—emerging new causes and treatments
Dix, C. H. K., & Hunt, B. J. (2024) · Journal of Thrombosis and Haemostasis · doi:10.1016/j.jtha.2024.08.012 · Cited by 22
Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism
Bitzer, J., Amy, J., Beerthuizen, R. J. C. M., Birkhäuser, M., Bombas, T., Creinin, M. D., Darney, P. D., Vicente, L. F., Gemzell‐Danielsson, K., Imthurn, B., et al. (2013) · Journal of Family Planning and Reproductive Health Care · doi:10.1136/jfprhc-2013-100624 · Cited by 22
Sex‐related differences in D‐dimer levels for venous thromboembolism screening
Reagh, J. J., Zheng, H., Stolz, U., Parry, B. A., Chang, A. M., House, S. L., Giordano, N. J., Cohen, J. E., Singer, A. J., Francis, S., et al. (2021) · Academic Emergency Medicine · doi:10.1111/acem.14220 · Cited by 22
Hematological Profile Changes Among Oral Contraceptive Users: A Narrative Review
Tekle, E., Gelaw, Y., & Asrie, F. (2022) · Journal of Blood Medicine · doi:10.2147/jbm.s379841 · Cited by 22
Family history of venous thromboembolism is a risk factor for venous thromboembolism in combined oral contraceptive users: a nationwide case-control study
Zöller, B., Ohlsson, H., Sundquist, J., & Sundquist, K. (2015) · Thrombosis Journal · doi:10.1186/s12959-015-0065-x · Cited by 22
Estimate of Venous Thromboembolism and Related-Deaths Attributable to the Use of Combined Oral Contraceptives in France
Tricotel, A., RAGUIDEAU, F., Collin, C., & Zureik, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093792 · Cited by 22

Authors: Lidegaard, O., Lokkegaard, E., Svendsen, A. L., & Agger, C.
Affiliations: University of Copenhagen (DK)
Venue: BMJ
Publisher: BMJ
Published: 2009-08-13
Volume: 339
Issue: aug13 2
Pages: b2890-b2890
ISSN: 0007-1447 (ISSN-L)
0959-8138
1468-5833
DOI: 10.1136/bmj.b2890
PMC: PMC2726928
OpenAlex: W2027062965
Cited by: 709
References: 29
Citations by year: 2026: 19 · 2025: 39 · 2024: 17 · 2023: 27 · 2022: 35 · 2021: 42 · 2020: 33 · 2019: 31 · 2018: 34 · 2017: 46 · 2016: 32 · 2015: 41 · 2014: 61 · 2013: 74 · 2012: 45
FWCI: 44.51
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc
Locations: BMJ (publishedVersion, cc-by-nc)
Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
PubMed Central (publishedVersion, cc-by-nc)
PubMed (publishedVersion)
Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
Funders: Rigshospitalet
Topics: Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
Keywords: hormonal contraception, venous thromboembolism, deep vein thrombosis, pulmonary embolism, oral contraceptives, estrogen dose, progestogens, levonorgestrel, norethisterone, desogestrel, gestodene, drospirenone, cyproterone, route of administration, duration of use, thrombosis risk
MeSH terms: Adolescent, Adult, Contraceptives, Oral, Combined, Contraceptives, Oral, Hormonal, Denmark, Epidemiologic Methods, Female, Humans, Middle Aged, Age Distribution, Venous Thromboembolism, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Hormonal contraception and risk of venous thromboembolism: national follow-up study

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks